Fujifilm acquires US Kalon Biotherapeutics, a CMO

Through her subsidiary Diosynth Biotechnologies USA, Fujifilm has acquired this company for an amount of several billion Yen

Fujifilm news release, Oct. 27, 2014

Fujifilm acquires US Kalon Biotherapeutics, a CMO
Scroll to top